Related by context. All words. (Click for frequent words.) 72 novel emulsion formulation 70 MAGE A3 ASCI 70 pharmacodynamic properties 69 statistically significant superiority 69 interferon gamma 1b 68 reduce serum phosphate 68 pharmacologically active isomer 68 bovine thrombin 68 Cleviprex TM clevidipine 68 CTAP# Capsules 68 ARIKACE ™ 68 Oracea TM 68 analgesic efficacy 68 CIMZIA ™ 67 oxaliplatin Eloxatin 67 PSMA ADC 67 R sorafenib tablets 67 trastuzumab Herceptin R 67 morphometric vertebral fractures 67 Navelbine ® 67 hyperphenylalaninemia HPA due 67 Pemetrexed 67 ZOLINZA 67 Pruvel 67 itraconazole Sporanox 67 sorafenib tablets 67 viral kinetics 67 CYT# potent vascular disrupting 67 posaconazole 67 fusion enhancers 67 Spiegelmer ® 67 sorafenib Nexavar 67 plasma kallikrein inhibitor 67 adenosine injection 67 evaluating tivozanib 67 acetonide FA 67 metaglidasen 67 CINQUIL 67 rhITF 67 HMG CoA reductase inhibitors 67 rabeprazole 67 amifostine 67 miconazole Lauriad ® 67 urinary N telopeptide 67 somatostatin analog 67 successfully commercialize Iluvien 67 riociguat 67 Mg Uk 67 EDEMA3 trial 66 demonstrated antitumor activity 66 Non inferiority 66 R Saizen R 66 INSPIRE Trial Phase III 66 K ras mutations 66 Cancidas 66 DexaSite 66 oral diclofenac 66 Navelbine 66 pharmacokinetic parameters 66 pharmacodynamic PD 66 Degarelix 66 relapsed MM 66 oral ridaforolimus 66 preclinically 66 pharmacokinetic PK study 66 FOLFOX6 chemotherapy regimen 66 Fludara ® 66 pharmacodynamic profiles 66 DU #b 66 mertansine 66 pegylated IFN 66 xanthine oxidase inhibitor 66 lumiliximab 66 salmeterol fluticasone 66 NATRECOR ® 66 Known hypersensitivity 66 Elvitegravir 66 bioequivalency 66 liposomal formulation 66 erlotinib Tarceva ® 66 NeuroSTAT ® 66 AAG geldanamycin analog 66 beta 1a 66 vidofludimus 66 Epirubicin 66 Perforomist ™ Inhalation Solution 66 oral prodrug 66 Proellex TM 66 cardiac repolarization 66 dose proportionality 66 Archexin 66 oxymorphone ER 66 CRMD# 66 zoledronate 66 radezolid 65 tigecycline 65 vinorelbine tartrate 65 Onconase 65 vapreotide acetate 65 efficacy tolerability 65 Temsirolimus 65 potency selectivity 65 pegylated interferons 65 SPRYCEL ® 65 pain palliation 65 Vidaza ® 65 AzaSite Plus 65 thalidomide Thalomid 65 velafermin 65 synthetic peptide containing 65 PEGylated anti 65 Anticalins ® 65 trastuzumab Herceptin ® 65 cisplatin gemcitabine 65 1mg 2mg 65 bronchodilatory 65 Xanafide 65 teriflunomide 65 active comparator 65 QuadraSphere 65 PROCHYMAL 65 wilate ® 65 hematological parameters 65 DPX Survivac 65 torsemide ER 65 abacavir lamivudine 65 thetreatment 65 Panzem R NCD 65 JAK inhibitor 65 pan HDAC inhibitor 65 docetaxel emulsion 65 CIMZIA TM certolizumab pegol 65 MGd 65 pharmacodynamic parameters 65 SILENOR 65 mTOR kinase 65 systemic immunosuppressive drugs 65 Danazol 65 candidate TNFerade biologic 65 Exforge HCT 65 GW# [003] 65 Zemplar Capsules 65 gemcitabine cisplatin 65 IMiDs ® 65 Solorel TM 65 topical gel formulation 65 pioglitazone HCl 65 oral salmon calcitonin 65 CYP#A# CYP#D# 65 DAVANAT 65 huC# DM4 65 orally inhaled 65 OMNARIS HFA 65 Ophena TM 65 aspirin clopidogrel 65 hemostatic efficacy 65 denileukin diftitox 65 Oral NKTR 65 oral rivaroxaban 65 elotuzumab 65 biologic DMARD 65 humanised monoclonal antibody 65 serum phosphorous 65 BRAF inhibitor 65 pegylated liposomal doxorubicin 65 noninferiority 65 meropenem 65 idraparinux 65 unresectable tumors 65 systemically administered 65 Anidulafungin 65 MYDICAR ® 65 RhuDex ® 65 CaPre TM 65 cangrelor 65 Azedra 65 nicardipine 65 intranasal formulation 65 IMA# 65 RoACTEMRA 65 pharmacodynamic effects 65 tolevamer 65 brand ciclesonide HFA 65 ChronVac C R 64 coronary stent merged 64 novel VDA molecule 64 RAPAFLO TM 64 CANCIDAS 64 Androxal TM 64 intravenous AAT 64 FUSILEV enhances 64 Gilead Viread 64 tecarfarin 64 BENICAR HCT 64 Carvedilol 64 favorable pharmacokinetic profile 64 ADAGIO study 64 INVEGA ® 64 Fondaparinux 64 BUPHENYL R sodium phenylbutyrate 64 pharmacokinetic interactions 64 delafloxacin 64 EGS# 64 alkylating agent 64 maximally tolerated dose 64 Zoraxel 64 mapatumumab 64 Effexor venlafaxine 64 Sanofi Aventis Taxotere 64 sitaxsentan 64 Ketotransdel 64 SinuNase ™ 64 RLY# 64 Meets Primary Endpoint 64 antitumor effect 64 alpha interferons 64 Pharmacokinetic parameters 64 Safinamide 64 oral deforolimus 64 BrachySil TM 64 pharmacodynamics PD 64 HyQ 64 LEVADEX ™ 64 IIIa inhibitor 64 Xcytrin R 64 FOSRENOL ® 64 plasma pharmacokinetics 64 HuMax EGFr 64 D aspartate NMDA receptor 64 chemotherapy induced neutropenia 64 docetaxel Taxotere ® 64 clevidipine 64 Pharmacokinetic studies 64 opioid naïve 64 IMiDs 64 NB S# strontium malonate 64 nalbuphine ER 64 VELCADE melphalan 64 #I TM# 64 haematologic 64 Zenvia ™ 64 trastuzumab DM1 64 galiximab 64 busulfan 64 OvaRex ® MAb 64 Xeloda ® 64 LymphoStat B belimumab 64 fondaparinux 64 paroxetine sertraline 64 Mycophenolate Mofetil 64 NS5B polymerase 64 SYNERGY Stent 64 Zybrestat 64 ramipril Altace 64 Tß4 64 adecatumumab 64 liposomal amphotericin B 64 ocular formulation 64 Mg Usa 64 PrevOnco 64 DuraSite ® 64 Pegloticase 64 Selective Serotonin Reuptake Inhibitor 64 echocardiographic parameters 64 miconazole 64 sunitinib Sutent 64 Dabigatran etexilate 64 bendamustine 64 Trastuzumab DM1 64 basal bolus regimen 64 Aptivus ® 64 baminercept 64 methylnaltrexone bromide 64 HGS ETR1 mapatumumab 64 pertuzumab 64 ELACYT 64 ENMD # 64 alvespimycin 64 Zorbtive TM 64 COREG CR 64 FOLFOX6 64 catheter occlusion 64 hyaluronidase enzyme 64 Noxafil 64 PEGINTRON TM 64 ACTEMRA TM 64 acyclovir Lauriad ® 64 Trofex 64 gemcitabine carboplatin 64 fosbretabulin 64 pregabalin Lyrica 64 corticosteroid dexamethasone 64 tolerability pharmacokinetics 64 IOP lowering 64 oxcarbazepine 64 candidates Azedra TM 64 Alkeran 64 TNF Tumor Necrosis Factor 64 intranasal delivery 64 ruxolitinib 64 REMINYL ® 64 arsenic trioxide injection 64 Achieves Primary Endpoint 64 JAK inhibitors 64 lanthanum carbonate 64 azilsartan medoxomil 64 immune modulatory 64 EOquin TM 64 orally inhaled migraine 64 pharmacokinetic characteristics 64 desvenlafaxine succinate 64 tipranavir 64 Tekturna HCT 64 fluoropyrimidine 64 XP# XP# 64 efaproxiral 64 Aggrastat ® tirofiban hydrochloride 64 delivers fluocinolone acetonide FA 64 diarrhea predominant irritable 64 Erlotinib 64 HCl capsules 64 Vidaza azacitidine 64 Progenta TM 64 Taxol ® 63 malignant ascites 63 bevacizumab Avastin ® 63 intravenous cyclophosphamide 63 Irinotecan 63 Aplidin 63 Ventavis ® 63 LEP ETU 63 Sebivo 63 Azacitidine 63 Poly ICLC 63 Etoposide 63 fluvastatin 63 TELINTRA 63 endothelin antagonists 63 regorafenib 63 Sudhir Agrawal D.Phil 63 docetaxel Taxotere 63 DermaVir Patch 63 STRIDE PD 63 LHRH antagonists 63 SNT MC# 63 tanespimycin 63 Azedra TM 63 SNT-MC#/idebenone 63 Ixempra 63 trospium 63 lenalidomide dexamethasone 63 Seliciclib 63 EDEMA3 63 Gemzar ® 63 cytostatic 63 Amrubicin 63 cannabinor 63 COLAZAL R 63 tranylcypromine 63 ACAPODENE TM 63 LymphoStat B TM 63 recombinant interferon 63 MetroGel 63 HCV protease inhibitors 63 HMG CoA reductase inhibitor 63 Tesmilifene 63 Hsp# Inhibitor 63 Presents Preclinical 63 lipid lowering agents 63 mesylate 63 S/GSK# 63 Initiates Enrollment 63 proteasome inhibitor 63 herpetic keratitis 63 Emtriva Viread 63 Darinaparsin 63 preclinical efficacy 63 Doxycycline Tablets 63 YONDELIS 63 Tarceva TM 63 Personalized Immunotherapy 63 Dual Opioid 63 relapsed MCL 63 Ereska 63 Tasigna prolongs 63 Capesaris 63 davunetide intranasal AL 63 therapeutic equivalence 63 selective modulator 63 candesartan cilexetil 63 Fibrin Pad 63 OMNARIS Nasal Spray 63 kidney urologic 63 GRNVAC1 63 MyVax R 63 CYT# QbG# 63 Phase Ib study 63 efficacy endpoint 63 TPI ASM8 63 prednisone prednisolone plus 63 budesonide foam 63 ACUROX ® 63 ritonavir boosted 63 chimeric monoclonal antibody 63 pancreatic enzyme replacement 63 PrevOnco ™ 63 treat chronic sinusitis 63 Virulizin ® 63 Cloretazine 63 phase IIb trial 63 micafungin 63 paclitaxel Taxol ® 63 plus prednisone 63 liposome encapsulated 63 CIMZIA TM 63 Aflibercept 63 idarubicin 63 valtorcitabine 63 inhaled iloprost 63 FOLOTYN ® 63 alfuzosin 63 achieved statistical significance 63 Methylnaltrexone 63 vascular disrupting agents 63 macrolide antibiotic 63 Orally administered 63 Metvix 63 induce orthostatic hypotension 63 IMiDs ® compound 63 prostanoid 63 oral transmucosal 63 Initiate Clinical Trial 63 Ketotransdel TM 63 Dalbavancin 63 lenalidomide Revlimid R 63 midstage clinical 63 CoFactor 63 DOXIL 63 Doxil ® 63 mycophenolic acid 63 targeted radiotherapeutic 63 EmbraceAC 63 goserelin 63 Sanvar R 63 Anticalins R 63 DiLA2 63 epoprostenol 63 Interferon beta 63 TOCOSOL Camptothecin 63 AST ALT 63 ularitide 63 HuLuc# 63 COPEGUS 63 OMAPRO ™ 63 secondary hyperparathyroidism 63 ALN HPN 63 esophageal candidiasis 63 Nexavar sorafenib tablets 63 TLK# 63 oral talactoferrin 63 neratinib 63 orally disintegrating 63 nilotinib Tasigna ® 63 Retisert 63 gp# vaccine 63 concurrent chemoradiation 63 including eniluracil ADH 63 Besivance 63 Pertuzumab 63 hereditary deficiency 63 NV1FGF 63 faropenem 63 diabetic neuropathic pain 63 antiarrhythmic 63 GLYX 63 BAL# [002] 63 Telatinib 63 liposomal doxorubicin 63 Targretin capsules 63 trastuzumab emtansine T DM1 63 nonclinical studies 63 comparator arm 63 BYETTA exenatide injection 63 enzastaurin 63 Taxotere docetaxel 63 NP2 Enkephalin 63 SPRIX ® 63 Genasense ® oblimersen 63 ® lenalidomide 63 Menadione 63 Femara letrozole 63 angiographic outcomes 63 Cellegesic 63 Octreolin 63 Proquin XR 63 Taxol paclitaxel 63 anidulafungin 63 Civacir 63 pharmacokinetic profiles 63 eprotirome 63 selective A2A adenosine receptor 63 quinolone 63 Sanofi Pasteur Fluzone 63 T Pred 63 orBec 63 PEGylated interferon 63 thorough QT 63 evaluating REVLIMID 63 Prilosec omeprazole 63 Fosphenytoin 63 PI3K/Akt pathway inhibitor 63 antidepressant efficacy 63 Dementia Related Psychosis 63 vismodegib 63 HDL Selective Delipidation 63 OMP #M# 63 ergot derivatives 63 RezularTM 63 Exelixis compounds 63 5 HT3 antagonist 63 INCB# [003] 63 Alocrest 63 Evoltra ® 63 Interferon alpha 63 Pimavanserin 63 bexarotene 63 dasatinib Sprycel 63 opioid mediated 63 Ganciclovir 63 Vaxfectin R 63 invasive candidiasis 63 plus prednisone prednisolone 63 virus HCV protease inhibitor 63 Zemiva TM 63 aerosolized AAT 63 evaluating picoplatin 63 Silodosin 63 humanized monoclonal antibodies 63 everolimus eluting stents 63 hoFH 63 statistically significant efficacy 62 Aviptadil 62 ORENCIA ® 62 dorzolamide 62 clinically meaningful reductions 62 BEXXAR Therapeutic Regimen 62 LB# [003] 62 Onalta 62 Squalamine 62 eTag assays 62 Onrigin 62 Solulin 62 generation purine nucleoside 62 Valdoxan 62 indinavir 62 Solazed TM 62 Iloperidone 62 GSK# [001] 62 forodesine 62 Paliperidone ER 62 Pivotal Phase III 62 Thiovir 62 soft gelatin capsule 62 VANTAS ® 62 REBETOL combination 62 PDE4 inhibitor 62 dalteparin 62 Teriflunomide 62 APOPTONE 62 AEGR 62 2 methoxyestradiol 62 Vildagliptin 62 maximal tolerated 62 levocetirizine 62 limiting toxicity 62 BRAF inhibitors 62 CDP# 62 SinuNase TM 62 incyclinide 62 mecamylamine 62 inhalation powder 62 nonnucleoside reverse transcriptase inhibitors 62 octreotide acetate 62 oxybutynin gel 62 peginterferon alpha 2a 62 immunomodulatory properties 62 Psoraxine R 62 Zysolin TM 62 subcutaneous immunoglobulin 62 Campath ® 62 Granulocyte Colony Stimulating Factor 62 lamotrigine Lamictal 62 Bicalutamide 62 hypervascular tumors 62 pharmacokinetics PK 62 Soliris eculizumab 62 PEG IFN 62 #mg dose [002] 62 histone deacetylase HDAC inhibitor 62 deferiprone 62 IRX 2 62 edifoligide 62 brivaracetam 62 Valcyte tablets 62 Atripla combines 62 hemagglutination inhibition 62 Actimmune ® 62 radiolabeled TM# 62 cisplatin vinorelbine 62 enoxaparin sodium 62 bevacizumab Avastin R 62 GAMMAGARD 62 injectable formulations 62 zafirlukast 62 ATPace TM 62 Soriatane 62 myelofibrosis polycythemia vera 62 complete cytogenetic response 62 Fluticasone 62 clinicopathological features 62 neutropenia dehydration dyspnea 62 titrated glipizide 62 linear pharmacokinetics 62 multicenter Phase II 62 XP #L 62 ATACAND 62 RhuDex TM 62 G#DT 62 etanercept Enbrel 62 retapamulin 62 PRT# 62 Taxotere chemotherapy 62 Dapagliflozin 62 5mg dose 62 theranostic 62 ipratropium bromide 62 Levaquin levofloxacin 62 SIR Spheres 62 Ophena 62 reactogenicity 62 OvaRex R 62 antiangiogenic activity 62 indibulin 62 selective inhibition 62 IMiDs R 62 pegylated alpha interferon 62 Serostim ® 62 bezafibrate 62 cetuximab Erbitux R 62 OMS# 62 ALN PCS 62 APTIVUS R 62 OraTest R 62 Belerofon 62 invasive aspergillosis 62 CCR9 antagonist 62 serotonin norepinephrine reuptake inhibitor 62 peripherally acting 62 secondary efficacy endpoint 62 liposome formulation 62 microtubule inhibitor 62 adipiplon 62 boosted protease inhibitor 62 Vfend 62 doripenem 62 unfractionated heparin UFH 62 kinase inhibition 62 LEVAQUIN ® 62 SUTENT ® 62 VEGF inhibitors 62 mycophenolate mofetil 62 darifenacin 62 SERMs 62 Gelnique 62 biologic antibody 62 Aciphex R 62 #.#mg/dL 62 thromboxane A2 62 panitumumab Vectibix 62 docetaxel Taxotere R 62 ABELCET 62 IV bisphosphonates 62 albiglutide 62 Rebif ® 62 small molecule activators 62 infusional 62 active moiety 62 sargramostim 62 Neulasta R 62 atrasentan 62 PD LID 62 interferon alfa 2b 62 Thalomid ® 62 Campath alemtuzumab 62 CLORETAZINE TM VNP#M 62 KRN# 62 norethindrone acetate 62 antiemetics 62 interleukin IL -# 62 zonisamide SR 62 rheumatoid arthritis osteoarthritis ankylosing 62 anthracycline chemotherapy 62 orally administered inhibitor 62 sevelamer carbonate 62 Fulvestrant 62 monoclonal antibody IgG1 Mab 62 Emollient Foam 62 amphotericin B 62 QTc prolongation 62 Veregen TM 62 XmAb# 62 vinca alkaloid 62 pharmacodynamic profile 62 DepoDur TM 62 dalbavancin 62 Aganocide 62 MTP inhibitor 62 Fidaxomicin 62 irbesartan 62 miconazole MBT 62 peak plasma concentrations 62 cardioprotective effects 62 ARCALYST ® 62 colesevelam HCl 62 PROMACTA ® 62 erythropoietic 62 Dyloject TM 62 6R BH4 62 IgG1 antibodies 62 long acting bronchodilator 62 biochemical abnormalities 62 headache nasopharyngitis 62 Amlodipine Besylate 62 tenofovir emtricitabine 62 somatostatin analogues 62 Emezine 62 prostaglandin E1 62 Gamunex C 62 renal toxicity 62 antiandrogens 62 limiting toxicity DLT 62 cyclophosphamide methotrexate 62 Interferon beta 1a 62 protease inhibitor PI 62 recurrent metastatic ovarian cancer 62 Sporanox 62 Pharmacokinetics PK 62 pharmacodynamic markers 62 ceftazidime 62 neurologic progression 62 antiviral efficacy 62 PTHrP 62 intravesical infusion therapy 62 Firazyr 62 Phase III ADT 62 Hydrochloride tablets 62 PRIMO CABG 62 SAR# [004] 62 Dacogen injection 62 racemate 62 HGS ETR2 62 Zolinza 62 Prodarsan R 62 Afatinib 62 primidone 62 YONDELIS R 62 anthracycline taxane 62 betamethasone dipropionate 62 alemtuzumab MS 62 Inhalation Solution 62 HER2 expression 62 murine model 62 cardiovascular calcification 62 torezolid phosphate 62 heparanase 62 CHAMPION PCI 62 gemcitabine Gemzar 62 Nexavar sorafenib 62 iniparib 62 mGluR5 NAM 62 latanoprost 62 Bystolic nebivolol 62 PEG SN# 62 thienopyridines 62 EXPAREL ™ 62 hypoxia activated prodrug 62 Oral corticosteroids 62 schizophrenia CIAS 62 ospemifene 62 Shows Statistically Significant 62 noninfectious uveitis 62 Resten NG 62 Genentech Rituxan 62 Deforolimus 62 antihormonal 62 Dapoxetine 62 cromolyn sodium 62 A3 adenosine receptor 62 DDP# 62 alvimopan 62 sapropterin dihydrochloride Tablets 62 SNRI 62 bardoxolone methyl 62 relapsed ovarian cancer 62 ORENCIA R 62 Proxinium TM 62 Fodosine 62 pyrazinamide 62 peginterferon alfa 2b 62 ADVEXIN therapy 62 inhibitor RG# 62 antiangiogenic agent 62 phase IIb clinical 62 GLP toxicology studies 62 epigenetic therapies 62 Inhaled AAT 62 therapeutic monoclonal antibody 62 Preclinical studies suggest 62 histamine dihydrochloride 62 KNS # 62 statin monotherapy 62 Altastaph 62 CIP ISOTRETINOIN 62 Mitoxantrone 62 #beta estradiol 62 anaphylactic reactions bronchospasm 62 #mg BID [003] 62 #mg/#mg 62 BeneFIX 62 cediranib 62 clomipramine 61 adrenocorticotropic hormone ACTH 61 Tumor Response 61 T#I [002] 61 ATL# [001] 61 oral antidiabetic 61 standard chemotherapy regimen 61 intravenously administered 61 hydrochloride capsules 61 symptomatic VTE 61 Reclast Aclasta 61 dosage regimens 61 PHX# 61 viral kinetic 61 thromboembolic complications 61 ALA PDT 61 nasal antihistamine 61 dasatinib Sprycel ® 61 DPP4 61 AMMONUL R sodium phenylacetate 61 Tamsulosin 61 hyperplasia BPH 61 mesalazine 61 Platinol ® cisplatin 61 clinically meaningful differences 61 constipation OIC 61 humanized monoclonal 61 Engerix B 61 Moxifloxacin 61 multitargeted 61 UPLYSO 61 afamelanotide 61 Combo Stent 61 astemizole 61 polysaccharide polymer 61 ciclopirox 61 Pitavastatin 61 nosocomial pneumonia 61 bronchial hyperresponsiveness 61 convenient dosing regimens 61 Budesonide foam crofelemer 61 conventional DMARDs 61 AZILECT ® 61 Fenofibrate 61 BRILINTA 61 response CCyR 61 Keppra XR 61 caspofungin 61 novel histone deacetylase 61 QVAR ® 61 Panzem R 61 oral candidiasis 61 SIMCOR 61 Solazed 61 RE LY trial 61 icatibant 61 Zalypsis 61 mediated inhibition 61 Leukine ® 61 Myocet 61 nucleoside analog 61 OncoVEX GM CSF 61 Zarnestra 61 gadobutrol 61 TRANSDUR ® 61 fulvestrant 61 metastatic hormone refractory 61 BrachySil 61 diclofenac sodium 61 acitretin 61 Tekamlo 61 Abacavir 61 prokinetic agent 61 MICARDIS ® 61 carboplatin chemotherapy 61 Ambrisentan 61 Tolevamer 61 liposome injection 61 Eraxis 61 non porcine pancreatic 61 Omacetaxine 61 PDX pralatrexate 61 Copegus ribavirin 61 TransVax TM 61 FBPase 61 novel oral anticoagulant 61 Elocalcitol 61 SERCA2a 61 FOSRENOL R 61 rEV# 61 Chemophase 61 Arikace 61 piperacillin tazobactam 61 rxRNA 61 cefazolin 61 Altera Nebulizer System 61 Xelox 61 prasterone 61 IV Busulfex 61 VISICOL R 61 Tolvaptan 61 ZACTIMA 61 abacavir Ziagen 61 metabolomic profiles 61 endothelin receptor antagonists 61 Empatic ™ 61 Kepivance 61 zalutumumab 61 nitrofurantoin 61 antimetabolite 61 EndoTAGTM 1 61 FS Antihemophilic Factor Recombinant 61 treat atopic dermatitis 61 tinidazole 61 Kinoid 61 severe hypersensitivity reactions 61 CTA# Injection 61 USL# 61 Captisol enabled 61 Carfilzomib 61 vivo potency 61 NMDA antagonists 61 MERREM 61 Generx TM 61 CCR5 receptor antagonist 61 AERx ® 61 pharmacoeconomic 61 Foradil Aerolizer 61 bactericidal activity 61 levoleucovorin 61 Hycamtin ® 61 NanoTab 61 Frova ® 61 ciprofloxacin hydrochloride 61 genotypic resistance 61 Vancocin R 61 tumor necrosis 61 Toremifene 61 mg BID dose 61 plus COPEGUS 61 oral Hycamtin 61 CCR5 mAb 61 HIF PH inhibitors 61 docetaxel chemotherapy 61 acyclovir Lauriad R 61 MiStent DES 61 Refractory Hodgkin Lymphoma 61 AVE# 61 Orphan Status 61 beta lactam antibiotic 61 metastatic neuroendocrine tumors 61 anticancer activity 61 personalized cellular immunotherapy 61 MP4OX 61 refractory gout 61 Novolimus 61 p# biomarkers 61 immunotherapeutic vaccine 61 NS#/#A protease 61 Elotuzumab 61 Phase IIb clinical trials 61 Abiraterone acetate 61 antithrombotics 61 dihydrochloride 61 fluoxetine paroxetine 61 lanreotide 61 Tolerability 61 levosimendan 61 mTOR inhibition